Product image of Liprolog Mix50 Kwikpen (Insulin Lispro) supplied by GNH India

Liprolog Mix50 Kwikpen

Active Ingredient:
Insulin Lispro
Origin:
EU

Liprolog Mix50 Kwikpen (Insulin Lispro)

Insulin lispro, the active ingredient in Liprolog Mix50 Kwikpen, is a rapid‑acting insulin analog presented as a pre‑filled Kwikpen for subcutaneous use. It treats diabetes mellitus by lowering blood glucose levels in adults and children who require insulin therapy.

GNH India supplies Liprolog Mix50 Kwikpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eli Lilly Nederland B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Insulin lispro is used to manage hyperglycemia in diabetes mellitus and related conditions.

  • Type 1 diabetes mellitus: provides rapid mealtime glucose control.
  • Type 2 diabetes mellitus: adjunct to oral agents for postprandial glucose reduction.
  • Gestational diabetes mellitus: helps achieve target post‑meal glucose levels during pregnancy.

How It Works

  • Insulin lispro binds to insulin receptors on muscle and adipose cells, activating the receptor’s tyrosine kinase activity. This triggers intracellular signaling that promotes translocation of GLUT‑4 transporters to the cell membrane, enhancing glucose uptake and utilization while suppressing hepatic glucose production, resulting in lowered blood glucose concentrations.

Side Effects

Adverse reactions may occur with any insulin therapy.

Common Side Effects

  • Hypoglycemia: low blood glucose episodes.
  • Injection site reactions: redness, swelling, or itching.
  • Weight gain: increase in body weight over time.
  • Lipodystrophy: localized fat tissue changes at injection sites.
  • Localized allergic reactions: rash or pruritus.

Serious or Rare Side Effects

  • Severe hypoglycemia: loss of consciousness or seizures.
  • Anaphylaxis: life‑threatening allergic response.
  • Hypokalemia: low potassium levels.
  • Edema: fluid retention causing swelling.
  • Urticaria: hives or widespread rash.
  • Insulin antibody formation: may affect insulin efficacy.

Precautions & Warnings

Careful monitoring and patient education are essential when using rapid‑acting insulin.

  • Blood glucose monitoring: adjust dose based on frequent measurements.
  • Hypoglycemia risk: recognize symptoms and have fast‑acting carbohydrate available.
  • Renal or hepatic impairment: may require dose reduction.
  • Pregnancy and lactation: limited data; use only if clearly needed.
  • Concomitant beta‑blockers: may mask hypoglycemia signs.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Insulin lispro can interact with several drug classes, affecting glucose control.

Major Interactions (Avoid)

  • Sulfonylureas or meglitinides: additive hypoglycemic effect, risk of severe hypoglycemia.
  • High‑dose glucocorticoids: may necessitate insulin dose increase, careful monitoring required.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycemia symptoms.
  • ACE inhibitors or ARBs: may potentiate insulin’s glucose‑lowering effect.
  • Diuretics: can alter potassium levels, influencing insulin action.
  • Alcohol: enhances hypoglycemia risk, especially with missed meals.
  • Oral contraceptives: may affect insulin sensitivity.

Frequently Asked Questions

Liprolog Mix50 Kwikpen contains insulin lispro, a rapid‑acting insulin analog used to control post‑prandial blood glucose in people with type 1 or type 2 diabetes who require mealtime insulin therapy.

Insulin lispro binds to insulin receptors, quickly activating cellular pathways that move glucose transporters to the cell surface, thereby increasing glucose uptake into muscle and fat cells and suppressing liver glucose output.

The dose is individualized. A qualified prescriber determines the amount and timing of each injection based on the patient’s blood‑glucose profile, carbohydrate intake, and overall treatment plan.

Safety data are limited. It should be used in pregnancy or while breastfeeding only if the potential benefit justifies the potential risk to the fetus or infant, and under close medical supervision.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Insulin lispro has a faster onset and shorter duration than regular human insulin, similar to other rapid‑acting analogs such as insulin aspart and insulin glulisine. Choice among them often depends on physician preference, patient response, and formulary considerations.

Store the Kwikpen at 2‑8 °C (refrigerated) in its original carton, protect it from light, and do not freeze or shake the pen. Once in use, it may be kept at room temperature for up to 28 days, as indicated on the label.

The pre‑filled Kwikpen is designed for subcutaneous injection. After selecting the prescribed dose, the user inserts the needle, presses the injection button, and holds the pen against the skin for a few seconds before withdrawing.

The most serious risks include severe hypoglycemia, which can lead to loss of consciousness or seizures, and rare allergic reactions such as anaphylaxis. Patients should be educated on recognizing symptoms and seeking immediate medical help if they occur.

Individuals with a known hypersensitivity to insulin lispro or any excipients in the pen, as well as those experiencing severe hypoglycemia unawareness, should avoid using this product. Clinical judgment is required for patients with certain medical conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Insulin Lispro

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT